ENTITY
Hutchison China MediTech Ltd

Hutchison China MediTech Ltd (HCM US)

41
Analysis
Health CareHong Kong
Hutchison China MediTech Ltd develops, manufactures, and sells pharmaceutical products. The Company offers drugs for oncology and autoimmune diseases treatment. Hutchison China MediTech markets its products globally.
more
08 Jun 2021 14:24

China ADRs - A New Act Aims to Put an End to China ADR IPOs

On 27th May 2021, U.S. Senators Marco Rubio and Bob Casey introduced the No IPOs for Unaccountable Actors Act, which aims to prohibit IPO on U.S....

Logo
313 Views
Share
bullishCoupang
14 Mar 2021 10:15

ECM Weekly (14th March 2021) - Coupang, Baidu, Shanghai Heartcare, Chaoju Eye Care, Linklogis, Tuya

Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.

Share
10 Feb 2021 09:34

InnoCare Pharma Ltd (9969.HK) - What Attracts Both Hillhouse and Vivo Capital?

The article analyzed what InnoCare attracts both Hillhouse and Vivo Capital in terms of its core product orelabrutinib, other products (ICP-192/ICP...

Logo
320 Views
Share
bullishBeiGene
10 Jan 2021 05:35

BeiGene: Cancer Treatment in China--The Underestimated Opportunity

We think that cancer is underdiagnosed and undertreated in China. We analyze the data and propose two approaches for investing in this theme.

Share
03 Jan 2021 09:27

China Healthcare Weekly (Dec.31)

This article summarized the industry viewpoints including the results of China 2020 medical insurance negotiations, TDDS, companies news of...

Logo
324 Views
Share
x